Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes risk factors

Journal articles and book chapters

11-28-2018 | Diabetic cardiomyopathy | Article

Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

Rubio-Almanza M, Cámara-Gómez R, Hervás-Marín D et al. BMC Endocr Disord 2018; 18: 90. doi: 10.1186/s12902-018-0317-4

11-06-2018 | Risk factors | Article

Bisphenol A exposure and type 2 diabetes mellitus risk: A meta-analysis

Hwang S et al. BMC Endocr Disord 2018; 18: 81. doi: 10.1186/s12902-018-0310-y

09-12-2018 | SGLT2 inhibitors | Article

Comparative risk of genital infections associated with SGLT2 inhibitors: A real‐world retrospective cohort study

Dave CV et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13531

09-12-2018 | Retinopathy | Article

The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: A meta-analysis

Cai X et al. Endocrine 2018. doi: 10.1007/s12020-018-1697-y

08-31-2018 | GLP-1 agonists | Review | Article

Cardiovascular effects of different GLP-1 receptor agonists in patients with type 2 diabetes

Bahtiyar G, Pujals-Kury J, Sacerdote A. Curr Diab Rep 2018; 18: 92. doi: 10.1007/s11892-018-1043-z

08-29-2018 | Risk factors | Review | Article

Early-life exposures and risk of diabetes mellitus and obesity

Gingras V, Hivert MF, Oken E. Curr Diab Rep 2018; 18: 89. doi: 10.1007/s11892-018-1050-0

08-28-2018 | Diet | Review | Article

Dietary interventions and type 2 diabetes in youth: A fresh look at the evidence

Perkison WB, Adekanye JA, de Oliveira Otto MC. Curr Nutr Rep 2018. doi: 10.1007/s13668-018-0241-2

08-22-2018 | Retinopathy | Article

Glucagon-like peptide-1 receptor agonists and the risk of incident diabetic retinopathy

Douros A et al. Diabetes Care 2018: dc172280. doi: 10.2337/dc17-2280

08-17-2018 | Diabetes prevention | Article

Understanding the complexity of glycemic health: Systematic bio-psychosocial modeling of fasting glucose in middle-age adults - A DynaHEALTH study

Lowry E et al. Int J Obes 2018. doi: 10.1038/s41366-018-0175-1

08-17-2018 | Cardiovascular disorders | Article

Age-related differences in glycemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: A cross-sectional study from the Australian National Diabetes Audit

Nanayakkara N et al. BMJ Open 2018; 8: e020677. doi: 10.1136/bmjopen-2017-020677

08-16-2018 | Gestational diabetes | Review | Article

Prediction and prevention of type 2 diabetes in women with a history of GDM

Tobias DK. Curr Diab Rep 2018; 18: 78. doi: 10.1007/s11892-018-1063-8

08-13-2018 | Glycemic control | Article

The legacy effect in type 2 diabetes: Impact of early glycemic control on future complications (the Diabetes & Aging Study)

Laiteerpong N et al. Diabetes Care 2018: dc171144. doi: 10.2337/dc17-1144

08-06-2018 | Cardiovascular outcomes | Article

Glycemic variation and cardiovascular risk in the Veteran’s Affairs Diabetes Trial

Zhou JJ et al. Diabetes Care 2018: dc180548. doi: 10.2337/dc18-0548

07-25-2018 | Retinopathy | Article

Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: A retrospective cohort study

Li YH, Sheu WH, Lee IT. BMJ Open 2018; 8: e021655. doi: 10.1136/bmjopen-2018-021655

07-14-2018 | Pediatrics | Review | Article

Disparities in care delivery and outcomes in young adults with diabetes

Agarwal S, Hilliard M, Butler A. Curr Diab Rep 2018; 18: 65. doi: 10.1007/s11892-018-1037-x

07-09-2018 | Neuropathy | Article

Risk-factor trajectories preceding diabetic polyneuropathy: ADDITION-Denmark

Andersen ST et al. Diabetes Care 2018. doi: 10.2337/dc18-0392

07-06-2018 | Osteoporosis | Article

FRAX tool in type 2 diabetic subjects: The use of HbA1c in estimating fracture risk

Valentini A et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1187-y

07-04-2018 | Mental health | Article

Factors associated with type 2 diabetes in patients with vascular dementia: A population-based cross-sectional study

Liu CL et al. BMC Endocr Disord 2018; 18: 45. doi: 10.1186/s12902-018-0273-z

07-03-2018 | Type 2 diabetes | Article

Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the UK Biobank, and their modification by smoking

Jenkins DA et al. Diabetes Care 2018. doi: 10.2337/dc17-2508

07-02-2018 | Cardiovascular disorders | Article

The relationship between circulating adiponectin, ADIPOQ variants and incident cardiovascular disease in type 2 diabetes: The Fremantle Diabetes Study

Peters KE et al. Diabetes Res Clinc Prac 2018; 143: 62–70. doi: 10.1016/j.diabres.2018.06.005

Next
Image Credits